UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Massachusetts 04-2103460 (State or Other Jurisdiction of Incorporation or Organization) 68 Jonspin Road, Wilmington, MA 01887 (Address of Principal Executive Offices) (Zip Code) (I.R.S. Employer Identification No.) Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol | Name of each exchange on ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 4D Molecular Therapeutics Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39782 47-3506994 (State or Other Jurisdiction of Incorporation) 5858 HORTON STREET #455 EMERYVILLE, California 94608 (Address of Principal Executive Offices) (Zip Code) (Commissio ...

Exhibit 99.1 FOR IMMEDIATE RELEASE FRIDAY, JANUARY 10, 2025 HURCO REPORTS FOURTH QUARTER AND FULL YEAR RESULTS FOR FISCAL YEAR 2024 INDIANAPOLIS, INDIANA – January 10, 2025 – Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2024. Hurco recorded a net loss of $1,442,000, or $(0.23) per diluted share, for the fourth quarter of fiscal year 2024, which included a non-cash tax valuation allowance of $193,000 recorded in provision for inco ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38166 CONCRETE PUMPING HOLDINGS, INC. (Exact name of Registrant as specified in its charter) (State or Other Jurisd ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | Date of Report (Date of earliest event reported) January 9, 2025 | | | | --- | --- | --- | | Brookdale Senior Living Inc. | | | | (Exact name of registrant as specified in its charter) | | | | Delaware | 001-32641 | 20-3068069 | | (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | 105 Westwood Place, Suite 400, | Brentwood, Tennessee | 37027 | | (Address of principal execu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 INOZYME PHARMA, INC. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) 321 Summer Street Suite 400 Boston, Massachusetts 02210 (Address of Principal Executive Offices) (Zip Code) (Commission File Number) Delaware 001-39397 38- ...

Exhibit 99.1 TD SYNNEX Reports Fiscal 2024 Fourth Quarter and Full Year Results FREMONT, CA and CLEARWATER, FL, January 10, 2025 – TD SYNNEX (NYSE: SNX) today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2024. Consolidated Financial Highlights for the Fiscal 2024 Fourth Quarter: GAAP ($ in millions, except earnings per share) Q4 FY24 Q4 FY23 Net Change from Q4 FY23 Revenue $ 15,844.6 $ 14,407.3 10.0 % Gross profit $ 1,040.9 $ 1,018.6 2.2 % Gross margin 6.57 % ...

Exhibit 99.1 Savers Value Village, Inc. Announces Preliminary Fourth Quarter and Full Year Net Sales and Participation in the 27 Annual ICR Conference th Reaffirms Previous Outlook for Adjusted EBITDA 1 Bellevue, WA – January 10, 2025 – Savers Value Village, Inc. (NYSE: SVV), (the "Company") today announced preliminary net sales for the thirteen weeks ended December 28, 2024 (the "fourth quarter") and the fifty-two weeks ended December 28, 2024 ("fiscal 2024") in conjunction with the Company's participation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Date of Report (Date of earliest event reported): January 10, 2025 BARINTHUS BIOTHERAPEUTICS PLC (Exact name of registrant as specified in its charter) England and Wales 001-40367 Not Applicable (State or other jurisdiction of incorporation) Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Commission File Number) (I.R.S. Employer Identification No.) Barinthus Biotherapeutics plc Unit 6-10, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 AXOGEN, INC. (Exact Name of Registrant as Specified in Charter) Minnesota (State or Other Jurisdiction of Incorporation or Organization) 001-36046 (Commission File Number) 41-1301878 (I.R.S. Employer Identification No.) 13631 Progress Boulevard, Suite 400 Alachua, Florida (Addr ...